Brief periods of hyperphagia cause renal injury in the obese Zucker rat

Kidney International

Volumn 56, Issue 5, 1999, Pages 1779-1787

  Gades, Matthew D ^a,b,c   Van Goor, Harry ^a,b,c   Kaysen, George A ^a,b,c,d   Johnson, Patricia R ^a,b,c   Horwitz, Barbara A ^a,b,c   Stern, Judith S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albuminuria; Glomerulosclerosis; Lipids; Mesangial expansion; Nephrotic syndrome; Nutrition; Obesity

Indexed keywords

ALBUMIN; CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HYPERPHAGIA; HYPERTRIGLYCERIDEMIA; KIDNEY INJURY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0032704792     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00731.x     Document Type: Article

References (38)

1. 1. KASISKE BL, O'DONNELL MP, KEANE WF: The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19(Suppl 1):1110-1115, 1992
2. 2. O'DONNELL MP, KASISKE BL, CLEARY MP, KEANE WF: Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med 106:605-610, 1985
3. 3. GRÖNE HJ, WALLI A, GRÖNE E, NIEDMANN P, THIERY J, SEIDEL D, HELMCHEN U: Induction of glomerulosclerosis by dietary lipids: A functional and morphologic study in the rat. Lab Invest 60:433-446, 1989
4. 4. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
5. 5. TOOD EL, ABERNETHY DR: Pharmacokinetics and dynamics of (+/-) verapamil in lean and obese Zucker rats. J Pharmacol Exp Ther 238:642-647, 1986
6. 6. BARRINGER DL, BUÑAG RD: Uneven blunting of chronotropic baroreflexes in obese Zucker rats. Am J Physiol 256(2 Part 2):H417-H421, 1989
7. 7. JOHNSON PR, STERN JS, HORWITZ BA, HARRIS RE, GREENE S: Longevity in obese and lean male and female rats of the Zucker strain: Prevention of hyperphagia. Am J Clin Nutr 66:890-903, 1997
8. 8. LIEPA GU, MASORO EJ, BERTRAND HA, YU BP: Food restriction as a modulator of age-related changes in serum lipids. Am J Physiol 238:E253-E257, 1980
9. 9. KEANE WF, KASISKE BL, O'DONNELL MP: Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis. Am J Nephrol 8:261-271, 1988
10. 10. KAMANNA VS, ROH DD, KIRSCHENBAUM MA: Hyperlipidemia and kidney disease: Concepts derived from histopathology and cell biology of the glomerulus. Histol Histopathol 13:169-179, 1998
11. 11. KAMANNA VS, KIRSCHENBAUM MA: Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 13:53-58, 1993
12. 12. SCHIRARDIN H, BACH A: Serum lipids in 8-to 35-day-old Zucker rats. Arch Int Physiol Biochim 89:201-206, 1981
13. 13. IWASAKI K, GLEISER CA, MASORO EJ, MCMAHAN CA, SEO EJ, YU BP: The influence of dietary protein source on longevity and age-related disease processes of Fisher rats. J Gerontol Biol Sci 43:B5-B12, 1988
14. 14. GADES MD, STERN JS, VAN GOOR H, NGUYEN D, JOHNSON PR, KAYSEN GA: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 53:130-135, 1998
15. 15. KAYSEN GA, WATSON JB: Mechanism of hypoalbuminemia in the 7/8-nephrectomized rat with chronic renal failure. Am J Physiol 243:F372-F378, 1982
16. 16. VAN GOOR H, FIDLER J, WEENING JJ, GROND J: Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation: Evidence for involvement of macrophages and lipids. Lab Invest 64:754-765, 1991
17. 17. RAIJ L, AZAR S, KEANE WF: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143, 1984
18. 18. VAN GOOR H, VAN DER HORST MLC, ATMOSOERODJO J, JOLES JA, VAN TOL A, GROND J: Renal apolipoproteins in nephrotic rats. Am J Pathol 142:1804-1812, 1993
19. 19. KAYSEN GA, JONES H JR, MARTIN V, HUTCHISON FN: A low protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 83:1623-1629, 1989
20. 20. SHIMAMURA T: Relationship of dietary intake to the development of glomerulosclerosis in obese Zucker rats. Exp Mol Pathol 36:423-434, 1982
21. 21. KASISKE BL, CLEARY MP, O'DONNELL MP, KEANE WF: Effects of carbohydrate restriction on renal injury in the obese Zucker rat. Am J Clin Nutr 44:56-65, 1986
22. 22. APPFL GB, BLUM CB, CHIEN S, KUNIS CL, APPEL AS: The hyperlipidemia of the nephrotic syndrome. N Engl J Med 312:1544-1548, 1985
23. 23. KLAHR S, BUERKERT J, PURKERSON ML: Role of dietary factors in the progression of chronic renal disease. Kidney Int 24:579-587, 1983
24. 24. HOTIA O, TAGUMA Y, MITSUOKA M, TAKESHITA K, TAKAHASHI H: Urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus in an early microalbuminuric stage. Nephron 58:23-26, 1991
25. 25. CLELAND SJ, PETRIE JR, UEDA S, ELLIOTT HL, CONNELL JM: Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol 25:175-184, 1998
26. 26. POLDERMAN KH, STEHOUWER CD, VAN KAMP GJ, GOOREN LJ: Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia 39:1284-1292, 1996
27. 27. ABRASS CK, SPICER D, RAUGI GJ: Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture. Kidney Int 46:613-620, 1994
28. 28. BUCKINGHAM RE, AL-BARAZANJI KA, TOSELAND CD, SLAUGHTER M, CONNOR SC, WEST A, BOND B, TURNER NC, CLAPHAM JC: Peroxisome proliferator-activated receptor-gamma agonist, rosiglilazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47:1326-1334, 1998
29. 29. BRONSON FH: Effect of food manipulation on the GnRH-LH-estradiol axis of young female rats. Am J Physiol 254(4 Part 2): R616-R621, 1988
30. 30. BIVENS CL, OLSTER DH: Ahnormal estrous cyclicity and behavioral hyporesponsiveness to ovarian hormones in genetically obese Zucker female rats. Endocrinology 138:143-148, 1997
31. 31. CLEARY MP, VASSELLI JR, GREENWOOD MR: Development of obesity in Zucker obese (fafa) rat in absence of hyperphagia. Am J Physiol 238:E284-E292, 1980
32. 32. VALENSI P, ASSAYAG M, BUSBY M, PARIÈS J, LORMEAU B, ATTALI JR: Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 20:574-579, 1996
33. 33. BASDEVANT A, CASSUTO D, GIBAULT T, RAISON J, GUY-GRAND B: Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 18:806-811, 1994
34. 34. CASSUTO D, BASDEVANT A, GIBAULT T, ALTMAN JJ, RAISON J, GUY-GRAND B: Microalbuminuria in obese subjects. Horm Metab Res 24:302-303, 1992
35. 35. HAFFNER SM, STERN MP, GRUBER MK, HAZUDA HP, MITCHELL BD, PATTERSON JK: Microalbuminuria: Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10:727-731, 1990
36. 36. COONROD BA, ELLIS D, BECKER DJ, BUNKER CH, KELSEY SF, LLOYD CE, DRASH AL, KULLER LH, ORCHARD TJ: Predictors of microalbuminuria in individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 16:1376-1383, 1993
37. 37. STIEGLER H, STANDL E, SCHULZ K, ROTH R, LEHMACHER W: Morbidity, mortality, and albuminuria in type 2 diabetic patients: A three-year prospective study of a random cohort in general practice. Diabet Med 9:646-653, 1992
38. 38. VASQUEZ B, FLOCK EV, SAVAGE PJ, NAGULESPARAN M, BENNION LJ, BAIRD HR, BENNETT PH: Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 26:127-133, 1984